Clinical Trials Directory

Trials / Sponsors / Catabasis Pharmaceuticals

Catabasis Pharmaceuticals

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of Edasalonexent With Midazolam and Deflazacort in Healthy Subjects
Healthy
Phase 12020-08-08
TerminatedAn Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Phase 32019-03-14
CompletedPhase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Muscular Dystrophy, Duchenne
Phase 32018-10-02
CompletedPhase 1/2 Study in Boys With Duchenne Muscular Dystrophy
Muscular Dystrophy, Duchenne
Phase 1 / Phase 22016-04-01
CompletedA Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hyperc
Hypercholesterolemia
Phase 22015-10-01
CompletedA 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharma
Hypercholesterolemia
Phase 12015-01-01
CompletedPilot Study To Assess CAT-2003 in Patients With Chylomicronemia
Lipoprotein Lipase Deficiency, Familial, Hyperlipoproteinemia Type I, Chylomicronemia, Familial
Phase 22014-03-01
CompletedPilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
Hyperlipidemias, Hypertriglyceridemia, Dyslipidemias
Phase 22013-10-01
CompletedPilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
Phase 22013-07-01
CompletedA Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-
Dyslipidemia
Phase 12012-11-01
CompletedA Study of CAT-1004 Biomarkers in Healthy Subjects
Assessment of Mechanistic Blood Biomarkers in Healthy Humans
Phase 12012-08-01
CompletedA Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 12011-12-01
CompletedSafety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers
Healthy
Phase 12011-09-01